Phase 3 Haemophilia A Clinical Trials

3 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–3 of 3 trials

Recruiting

Phase 3

Study to Provide Continued Access to Treatment for Patients Completing a Previous Trial With Efanesoctocog Alfa

Haemophilia A (Moderate or Severe)

Swedish Orphan Biovitrum104 enrolled21 locationsNCT06716814

Recruiting

Phase 3

A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A

Haemophilia AHaemophilia A With Inhibitors

Novo Nordisk A/S451 enrolled152 locationsNCT05685238

Recruiting

Phase 3

Efficacy and Safety Evaluation Study of SCT800 in Previously Untreated Hemophilia A Patients.

Haemophilia A

Sinocelltech Ltd.36 enrolled1 locationNCT07437404